TITLE

Herpes Simplex Lesions of Face Treated with Idoxuridine Applied by Spray Gun: Results of a Double-blind Controlled Trial

AUTHOR(S)
Juel-Jensen, B. E.; MacCallum, F. O.
PUB. DATE
April 1965
SOURCE
British Medical Journal;4/3/1965, Vol. 1 Issue 5439, p901
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64058262

 

Related Articles

  • Oral Acyclovir for Prevention of Herpes Simplex Virus Reactivation After Marrow Transplantation. Wade, James C.; Newton, Barbara; Flournoy, Nancy; Meyers, Joel D. // Annals of Internal Medicine;Jun84, Vol. 100 Issue 6, p823 

    Deals with a study of the effectiveness of oral acyclovir in the prevention of herpes simplex virus reactivation after marrow transplantation in a double-blind, placebo-controlled trial. Methodology used in the study; Results and discussion.

  • Herpid.  // Royal Society of Medicine: Medicines;2002, p281 

    This article presents information on the drug Herpid, a proprietary, prescription-only preparation of the antiviral idoxuridine. It can be used to treat infections of the skin by herpes simplex or herpes zoster, and is available in a form for topical application with its own applicator.

  • Aurelius E et al (Clin Infect Dis 2012; 54:1304–13).  // Clinical Infectious Diseases;Aug2012, Vol. 55 Issue 3, p478 

    A correction to the article "Long-term valaciclovir suppressive treatment after herpes simplex virus type 2 meningitis: a double-blind, randomized, controlled trial" that was published in the May 1, 2012 issue is presented.

  • Topical Resiquimod 0.01% Gel Decreases Herpes Simplex Virus Type 2 Genital Shedding: A Randomized, Controlled Trial. Mark, Karen E.; Corey, Lawrence; Tze-Chiang Meng; Magaret, Amalia S.; Meei-Li Huang; Selke, Stacy; Slade, Herbert B.; Tyring, Stephen K.; Warren, Terri; Sacks, Stephen L.; Leone, Peter; Bergland, Vicki A.; Wald, Anna // Journal of Infectious Diseases;5/1/2007, Vol. 195 Issue 9, p1324 

    Background. Resiquimod, an investigational immune response modifier and Toll-like receptor (TLR) 7 and 8 agonist, stimulates production of cytokines that promote an antigen-specific T helper type 1 (Th1)—acquired immune response. In animal models, induction of Th1-specific responses...

  • Independent Nurse: Clinical - Herpes simplex. Watkins, Jean // GP: General Practitioner;5/21/2010, p31 

    The article presents information about different forms of herpes simplex diseases. One of the common form of herpes simplex infections is cold sores on the lips and face. Genital herpes simplex is also common and its symptoms include pain, itching, burning and dysuria. Primary herpes simplex...

  • Virend heals herpes lesion.  // AIDS Patient Care & STDs;Apr96, Vol. 10 Issue 2, p132 

    Reports on the effectiveness of the antiviral drug Virend in genital herpes lesions. Results of a double-blind, placebo-controlled study on the use of the drug in AIDS patients with recurring genital herpes.

  • The Treatment of Herpetic Infections: State of the Art. Terezhalmy, G. T. // Quintessence International;Feb1981, Vol. 12 Issue 2, p133 

    The article focuses on the issue concerning the questionable use of antiviral chemotherapeutics for managing orally related primary and recurrent herpetic infections. The author cites that the application of photodynamic inactivation is intended for treating herpes hominis via exposure to...

  • Famciclovir twice daily is better than a single dose for recurring genital herpes.  // Modern Medicine;May97, Vol. 65 Issue 5, p58 

    Presents an abstract of the study `Oral Famciclovir for Suppression of Recurrent Genital Herpes Simplex Virus Infection in Women: A Multicenter, Double-Blind, Placebo-Controlled Trial,' by `G.J. Mertz, M.O. Loveless et al., published in the February 10, 1997 issue of `Archives of Internal Medicine.'

  • Famciclovir for Herpes Simplex Labialis Induced by Sunlight. Walling, Anne D. // American Family Physician;6/1/1999, Vol. 59 Issue 11, p3249 

    Presents a summary of the article `Peroral Famciclovir in the Treatment of Experimental Ultraviolet Radiation-Induced Herpes Simplex Labialis: A Double-Blind, Dose-Ranging, Placebo-Controlled, Multicenter Trial,' by S. L. Spruance, et al., published in the February 1999 issue of the `Journal of...

  • Penciclovir for treatment of herpes simplex labialis. Huffman, Grace Brooke // American Family Physician;10/15/1997, Vol. 56 Issue 6, p1651 

    Presents a summary of the article `Penciclovir Cream for the Treatment of Herpes Simplex Labialis. A Randomized, Multicenter, Doubleblind, Placebo-Controlled Trial,' by Spruance S.L., et al from the `Journal of American Medical Association' dated 1997. Mechanism of action of penciclovir cream;...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics